BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35350844)

  • 21. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis.
    Lu Y; Liu L; Li H; Chen B; Gu Y; Wang L; Feng C; Chen C; Chen Y; Sun W; Cui X; Cao M; Tao Y; Zhong J; Zhong H; Ni Y; Cai Y; Song M; Liu X; Shi Y; Su X
    Clin Microbiol Infect; 2023 Jun; 29(6):797.e1-797.e7. PubMed ID: 36773771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.
    Dai Z; Cai M; Yao Y; Zhu J; Lin L; Fang L; Li Z; Yi H; Chen B; Liang X
    Medicine (Baltimore); 2021 Apr; 100(14):e25233. PubMed ID: 33832082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
    Verweij PE; Latgé JP; Rijs AJ; Melchers WJ; De Pauw BE; Hoogkamp-Korstanje JA; Meis JF
    J Clin Microbiol; 1995 Dec; 33(12):3150-3. PubMed ID: 8586691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
    J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis.
    He Q; Zhang M; Feng C
    BMC Pulm Med; 2021 Dec; 21(1):414. PubMed ID: 34915889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients.
    Zhuang Q; Ma H; Zhang Y; Chen L; Wang L; Zheng L; Deng Z; Chen Z
    Can Respir J; 2017; 2017():3685261. PubMed ID: 29259396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza].
    Lin PC; Zeng JH; Su SS; Zhou Y; Chen JJ; Chen CS; Li YP
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1050-1056. PubMed ID: 33878831
    [No Abstract]   [Full Text] [Related]  

  • 31. Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum.
    Boyer J; Sedik S; Egger M; Dichtl K; Prattes J; Kriegl L; Krause R; Prüller F; Hoenigl M
    Mycoses; 2024 Jun; 67(6):e13756. PubMed ID: 38886163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
    D'Haese J; Theunissen K; Vermeulen E; Schoemans H; De Vlieger G; Lammertijn L; Meersseman P; Meersseman W; Lagrou K; Maertens J
    J Clin Microbiol; 2012 Apr; 50(4):1258-63. PubMed ID: 22301025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
    Mohammadi S; Khalilzadeh S; Goudarzipour K; Hassanzad M; Mahdaviani A; Aarabi N; Pourabdollah M; Sigari N
    Med Mycol; 2015 Sep; 53(7):709-16. PubMed ID: 26229150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the JF5-based Aspergillus galactomannoprotein lateral flow device for diagnosing invasive aspergillosis in cancer patients.
    Wan L; Cai X; Ling M; Kan J; Yin M; Wang H
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1221-1229. PubMed ID: 38625450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.
    Zhang S; Wang S; Wan Z; Li R; Yu J
    Biomed Res Int; 2015; 2015():943691. PubMed ID: 25685819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.
    Fortún J; Martín-Dávila P; Gomez Garcia de la Pedrosa E; Silva JT; Garcia-Rodríguez J; Benito D; Venanzi E; Castaño F; Fernández-Ruiz M; Lazaro F; García-Luján R; Quiles I; Cabanillas JJ; Moreno S; Aguado JM
    J Infect; 2016 Jun; 72(6):738-744. PubMed ID: 27025205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The diagnostic performance of galactomannan detection for invasive pulmonary aspergillosis in non-neutropenic hosts].
    Lin PC; Lai QQ; Zhou Y; Ye JR; Wu Q; Chen CS; Li YP
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Dec; 39(12):929-933. PubMed ID: 27938542
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
    Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
    Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
    Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
    Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.